Inflammatory Bowel Disease IV: Pharmacological Management
Inflammatory Bowel Disease V: Surgical Management
Targeted Cancer Therapies
Cystic Fibrosis: Management
Secondary Lymphoid Organs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 18, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
C Bonnet1, B De Prijck, M Lejeune
1Service d'hématologie clinique, Département de médecine, CHU Liège, Campus universitaire du Sart-Tilman, Belgique. cbonnet@ulg.ac.be
Diffuse Large B Cells Lymphoma (DLBCL), a common non-Hodgkin lymphoma, requires effective treatments. This review summarizes current knowledge and explores strategies to improve therapeutic outcomes for DLBCL patients.
Area of Science: